The role of Arg78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity

被引:27
|
作者
Jensen, AA
Sheppard, PO
O'Hara, PJ
Krogsgaard-Larsen, P
Bräuner-Osborne, H
机构
[1] Royal Danish Sch Pharm, Dept Med Chem, Neurosci Pharmabiotec Res Ctr, DK-2100 Copenhagen, Denmark
[2] Zymogenet Inc, Seattle, WA 98105 USA
关键词
mGlu(1) receptor; Arg(78); agonist binding; glutamic acid; quisqualic acid; mutagenesis;
D O I
10.1016/S0014-2999(00)00283-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabotropic glutamate receptors belong to family C of the G-protein coupled receptor superfamily. These receptors all possess large extracellular amino terminal domains, where agonist binding takes place. We have previously constructed a molecular model of the amino terminal domain of the mGlu(1) receptor based on a weak amino acid sequence similarity with a family of bacterial periplasmic binding proteins (PBPs). The residues Ser(165) and Thr(188) were demonstrated to be involved in agonist binding to the receptor. Here, we report that mutation of Arg(78) in the mGlu(1b) receptor to leucine or glutamate completely knocks out [H-3]quisqualic acid binding to the receptor. The constructed mutants, R78L and R78E, have also been characterized in a inositol phosphate assay. Here, the potency of (S)-glutamic acid and (S)-quisqualic acid was reduced 1000- and 100-fold, respectively, on R78L compared to the wild type (WT) receptor. (S)-Quisqualic acid was as potent on mutant R78E as it was on R78L, whereas (S)-glutamic acid was unable to activate R78E significantly at concentrations up to 10 mM. in conclusion, Arg(78) appears to be essential for agonist binding to the mGlu(1) receptor, most likely, through the formation of an ionic bond between its positively charged side chain and the distal acid group of the agonists. Furthermore, the different impact of the two mutations on (S)-glutamic acid and (S)-quisqualic acid potencies strongly indicates that while Arg(78) appears to be a common site of interaction for the agonists, the Group I subtype selectivity of (S)-quisqualic acid is probably determined by other residues in the amino terminal domain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [1] Recent Advances in the Medicinal Chemistry of the Metabotropic Glutamate Receptor 1 (mGlu1)
    Owen, Dafydd R. y
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08): : 394 - 401
  • [2] Metabotropic Glutamate Receptor 1 (mGlu1) Positive Allosteric Modulators Exhibit Differential Effects at the mGlu1/5 Heterodimer
    Holter, Kimberly
    Lei, Xia
    Niswender, Colleen
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [3] Synthesis and characterization of two pet radioligands for the metabotropic glutamate 1 (mGlu1) receptor
    Huang, Yiyun
    Narendran, Rajesh
    Bischoff, Francois
    Guo, Ningning
    Bae, Sung A.
    Hwang, Dah-Ren
    Lesage, Anne S.
    Laruelle, Marc
    SYNAPSE, 2012, 66 (12) : 1002 - 1014
  • [4] PERMISSIVE ROLE FOR MGLU1 METABOTROPIC GLUTAMATE RECEPTORS IN EXCITOTOXIC RETINAL DEGENERATION
    Liberatore, Francesca
    Bucci, Domenico
    Mascio, Giada
    Madonna, Michele
    Di Pietro, Paola
    Beneventano, Martina
    Puliti, Alda Maria
    Battaglia, Giuseppe
    Bruno, Valeria
    Nicoletti, Ferdinando
    Romano, Maria Rosaria
    NEUROSCIENCE, 2017, 363 : 142 - 149
  • [5] Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness
    Lesage, Anne
    Steckler, Thomas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 2 - 16
  • [6] Construction and expression of a functional metabotropic glutamate receptor 1α-GFP fusion protein (mGlu1α-GFP)
    Doherty, A
    Henley, JM
    Collingridge, GL
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 288 - 288
  • [7] Potentiation of GABAergic neurotransmission contributes to the neuroprotective effects of metabotropic glutamate 1 (mGlu1) receptor antagonists
    Cozzi, A
    Meli, E
    Carlà, V
    Pellicciari, R
    Moroni, F
    Pellegrini-Giampietro, DE
    NEUROPHARMACOLOGY, 2002, 43 (02) : 283 - 283
  • [8] Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice
    Smith, FL
    Smith, PA
    Dewey, WL
    Javed, RR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 492 (2-3) : 137 - 142
  • [9] Investigating the Molecular Mechanisms Underlying the Differential Subcellular Targeting of the Metabotropic Glutamate Receptor 1 (mGlu1) in the Cerebellar Cortex
    Mansouri, M.
    Lindner, H.
    Ferraguti, F.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 38 - 38
  • [10] Investigating the molecular mechanisms underlying the differential subcellular targeting of the metabotropic glutamate receptor 1 (mGlu1) in the cerebellar cortex
    Mansouri, M.
    Kasugai, Y.
    Schoenherr, S.
    Bertaso, F.
    Raynaud, F.
    Perroy, J.
    Fagni, L.
    Lindner, H.
    Fukazawa, Y.
    Shigemoto, R.
    Ferraguti, F.
    FEBS JOURNAL, 2013, 280 : 412 - 412